The workplace technology company is putting its best foot forward this holiday season by doing an act of kindness.

The Kenilworth-based drugmaker will provide between 60,000 and 100,000 doses of their treatment intended for hospital patients with severe cases of COVID-19.

Strategic investment from single biotech-focused institutional investor enables clinical development of cancer medicines.

Because of the limited supply, a task force led by Vice President of Patient Care Services and Chief Nursing Officer Linda Carroll will set the priorities for which staff members will get the shot first.

The partnership is expected to help boost COVID-19 testing capacity for the health care network, and enhance the quality and value of diagnostic services to patients and their doctors.

This marks the tenth time during the pandemic the executive order was renewed allowing the state to continue responding to challenges posed by the virus.

This marks the Teaneck-based digital corporation's ninth acquisition in 2020 as it expands its capabilities for clients globally in the key focus areas of data and AI, cloud, digital engineering and the Internet of Things.

The pharma giant's leadership is being accused of a litany of abuses, including gender and sexual orientation discrimination, harassment a “cult-like adherence” to retaliation that ended in firing, according to a suit filed in New Jersey Superior Court in Essex County.

Under the proposed bill, the data on the number of cases and fatalities among health workers and emergency personnel would be collected on a bimonthly basis by the New Jersey Department of Health.

The first such center opened in East Windsor during the week of Dec. 14 and three more followed in Middletown, Marlboro and Old Bridge. The containers can also be used to administer vaccines when the shots become widely distributed.

Funds will support health care and science workforce through STEM education.

With the support of this gift, investigators will accelerate laboratory discoveries pertaining to these disciplines into clinical treatments through more effective and efficiently designed clinical trials.